Partners Identification for client’s early-stage oncology based clinical product for late-stage clinical development and commercialization.
A medium pharmaceutical client based in the US, with innovative formulations to treat Head and Neck Cancer, involved DelveInsight to identify a co-development partner, for the US and European region. The client was interested to involve a pharmaceutical company with experience around oncology, capabilities to develop the product through its clinical development cycle and also support commercial manufacturing for launching the product in the two regions.